A wrongful death Xarelto lawsuit was filed on behalf of a woman who allegedly died due to uncontrollable Xarelto bleeding. 

Xarelto, an anticoagulant, has been named in hundreds of lawsuits claiming that Janssen Pharmaceuticals failed to warn against the potentially deadly Xarelto side effects that could follow.

The Xarelto lawsuit was filed by Richard R., on behalf of his wife Clara R., who allegedly suffered from extreme Xarelto bleeding and died of a subdural hematoma on April 27, 2013.

The Xarelto lawsuit stated, “Plaintiff has suffered and incurred damages, including medical expenses and economic and non-economic damages, and has suffered loss of consortium” as a result of Janssen Pharmaceutical’s actions.

Xarelto Side Effects

Xarelto belongs to a new class of anticoagulants that was created to be an alternative to warfarin. Warfarin is a blood thinner that requires its users to adhere to a strict diet and to get their blood checked regularly.

Xarelto was marketed as an “easy to use” alternative. It is most commonly prescribed to patients who undergo certain surgeries to prevent the risk of stroke in patients with non-valvular atrial fibrillation.

However, since its introduction to the market in 2011, hundreds of individuals have suffered from Xarelto bleeding. The internal bleeding caused by this drug has been described as uncontrollable because there is no antidote that doctors can give patients to slow the bleeding. Instead, they must simply wait until the drug has left the patient’s system.

Janssen Pharmaceuticals allegedly failed to adequately warn not only about the Xarelto bleeding that could occur but also about the lack of antidote.

If a warfarin patient suffers from internal bleeding, there is an antidote that can be applied. Xarelto bleeding is believed to be considerably more dangerous because of the lack of antidote.

Janssen is currently working on an antidote, but it has not yet been approved by the Food and Drug Administration (FDA).

Xarelto Lawsuit

This Xarelto lawsuit included claims of wrongful death, strict product liability, negligence, defective design, manufacturing defect, failure to warn, breach of express and implied warranty, fraudulent misrepresentation, fraudulent concealment, negligent misrepresentation, fraud and deceit, loss of consortium, and more.

The Xarelto lawsuit suggested that Clara’s life could have been extended if not for Xarelto side effects. It has also been claimed that had Janssen Pharmaceuticals warned against the risk of Xarelto bleeding and the lack of antidote that many patients, including Clara, may not have taken that drug.

This Xarelto Lawsuit is Case No. 2:15-cv-01339 and is part of the Xarelto MDL:  In Re: Xarelto (rivaroxaban) Products Liability Litigation MDL No. 2592, filed in the U.S. District Court of the Eastern District of Louisiana.